Transarterial embolization and percutaneous ethanol injection as an effective bridge therapy before liver transplantation for hepatitis c-related hepatocellular carcinoma

Gastroenterology Research and Practice

Volumn 2016, Issue , 2016, Pages

  Chedid, Marcio F ^a   Scaffaro, Leandro A ^a   Chedid, Aljamir D ^a   Maciel, Antonio C ^a   Cerski, Carlos Thadeu S ^a   Reis, Matheus J ^a   Grezzana Filho, Tomaz J M ^a   De Araujo, Alexandre ^a   Leipnitz, Ian ^a   Kruel, Cleber D P ^a   Alvares Da Silva, Mario R ^a   Kruel, Cleber R P ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MICROCATHETER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS ETHANOL INJECTION; TUMOR NECROSIS;

EID: 84956947927     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2016/9420274     Document Type: Article

References (21)

1. A. Forner, J. M. Llovet, and J. Bruix, "Hepatocellular carcinoma, " The Lancet, vol. 379, no. 9822, pp. 1245-1255, 2012.
2. J. Bruix and M. Sherman, "Management of hepatocellular carcinoma: an update, " Hepatology, vol. 53, no. 3, pp. 1020-1022, 2011.
3. H. Bismuth, P. E. Majno, and R. Adam, "Liver transplantation for hepatocellular carcinoma, " Seminars in Liver Disease, vol. 19, no. 3, pp. 311-321, 1999.
4. I. W. Graziadei, H. Sandmueller, P. Waldenberger, et al., "Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome, " Liver Transplantation, vol. 9, no. 6, pp. 557-563, 2003.
5. M. D. Kluger, K. J. Halazun, R. T. Barroso, et al., "Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation, " Liver Transplantation, vol. 20, no. 5, pp. 536-543, 2014.
6. J. Bruix, M. Sherman, J. M. Llovet, et al., "Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference, " Journal of Hepatology, vol. 35, no. 3, pp. 421-430, 2001.
7. J. Bruix and M. Sherman, "Management of hepatocellular carcinoma, " Hepatology, vol. 42, no. 5, pp. 1208-1236, 2005.
8. W. C. Chapman, M. B. M. Doyle, J. E. Stuart, et al., "Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation, " Annals of Surgery, vol. 248, no. 4, pp. 617-624, 2008.
9. D. Seehofer, M. Nebrig, T. Denecke, et al., "Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis, " Clinical Transplantation, vol. 26, no. 5, pp. 764-774, 2012.
10. A. S. Khan, K. J. Fowler, and W. C. Chapman, "Current surgical treatment strategies for hepatocellular carcinoma in North America, "World Journal of Gastroenterology, vol. 20, no. 41, pp. 15007-15017, 2014.
11. H. B. El-Serag, "Hepatocellular carcinoma, " The New England Journal of Medicine, vol. 365, no. 12, pp. 1118-1127, 2011.
12. E. Tsochatzis, M. Garcovich, L. Marelli, et al., "Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma, " Liver International, vol. 33, no. 6, pp. 944-949, 2013.
13. B. Franssen, K. Alshebeeb, P. Tabrizian, et al., "Differences in surgical outcomes between hepatitis b and hepatitis C-related hepatocellular carcinoma a retrospective analysis of a single North American center, " Annals of Surgery, vol. 260, no. 4, pp. 650-658, 2014.
14. Z. Hu, Z. Li, J. Xiang, et al., "Intent-to-treat analysis of liver transplant for hepatocellular carcinoma in the MELD era: impact of hepatitis C and advanced status, " Digestive Diseases and Sciences, vol. 59, no. 12, pp. 3062-3072, 2014.
15. C. T. Frenette, R. C. Osorio, J. Stark, et al., "Conventional tace and drug-eluting bead tace as locoregional therapy before orthotopic liver transplantation: comparison of explant pathologic response, " Transplantation, vol. 98, no. 7, pp. 781-787, 2014.
16. C. Spreafico, T. Cascella, A. Facciorusso, et al., "Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile, " CardioVascular and Interventional Radiology, vol. 38, no. 2, pp. 322-328, 2015.
17. U. Stampfl, J. L. Bermejo, C. M. Sommer, et al., "Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study, " Journal of Vascular and Interventional Radiology, vol. 25, no. 7, pp. 1018-1026, 2014.
18. W. C. Chapman, G. Klintmalm, A. Hemming, et al., "Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?" Journal of the American College of Surgeons, vol. 220, no. 4, pp. 628-637, 2015.
19. F. Y. Yao, N. Mehta, J. Flemming, et al., "Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria, " Hepatology, vol. 61, no. 6, pp. 1968-1977, 2015.
20. A. Cucchetti, F. Trevisani, M. Cescon, et al., "Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population, " Journal of Hepatology, vol. 56, no. 5, pp. 1089-1096, 2012.
21. C. Camma, G. Cabibbo, S. Petta, et al., "Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma, " Hepatology, vol. 57, no. 3, pp. 1046-1054, 2013.